<--- Back to Details
| First Page | Document Content | |
|---|---|---|
 Date: 2015-03-05 12:14:42Clinical research Toxicology Critical Path Institute Pre-clinical development Food and Drug Administration Drug development Biomarker Rofecoxib Adverse effect Pharmacology Pharmaceutical sciences Medicine |
Add to Reading List |
Translational Safety in Drug Development – Innovations and Challenges A Joint Regional Chapter Meeting with SCCSOT and the Critical Path Institute Accelerating the Path to a Healthier World
